FDA Inspection
SOLA Pharmaceuticals LLCSOLA Pharmaceuticals LLC – FDA Inspection, Dec 18, 2024
Record Details
This FDA Inspection record concerns SOLA Pharmaceuticals LLC, with an inspection on December 18, 2024, issued by the New Orleans District Office, covering human drugs.
View Company Profile
ID · c213fd93-f106-499a-806f-ef3b23614b3d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1256965
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.22(a)Lack of quality control unit
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of SOLA Pharmaceuticals LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 8, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 22, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for SOLA Pharmaceuticals LLC
- FDA Inspection 1258442 - 2025-01-08
- FDA Inspection 1088275 - 2019-03-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.